Skip to main content

Myeloproliferative Neoplasms Specialists

87 verified specialists treating myeloproliferative neoplasms from across the United States are listed on this page. Top affiliations among the highest-ranked specialists include Dana-Farber Cancer Institute, Cleveland Clinic, and University of Maryland Medical Center. Drill into a state below to find specialists nearer to you, or compare individual profiles for credentials, focus areas, and clinical depth.

Daniel Deangelo

Daniel Deangelo, M.D.,PH.D.

Chief, Division of Leukemia Institute Physician; Professor of Medicine, Harvard Medical School

Hematology

Boston, MA30+ years
Hematology & Oncology
Jaroslaw Maciejewski

Jaroslaw Maciejewski, MD

Professor of Medicine

Hematology

Cleveland, OH30+ years
Malignant Hematology
Maria Baer

Maria Baer, MD

Professor of Medicine and Professor of Molecular Medicine, University of Maryland School of Medicine

Hematology

Baltimore, MD30+ years
Hematology & Oncology
Ayalew Tefferi

Ayalew Tefferi, M.D.

Professor of Medicine / Consultant

Hematology

Rochester, MN30+ years
Malignant Hematology
Matt Kalaycio

Matt Kalaycio, MD

Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Hematology

Cleveland, OH30+ years
Hematology & Oncology
Naval Daver

Naval Daver, MBBS

Professor and Director of the Leukemia Research Alliance Program, Department of Leukemia, MD Anderson Cancer Center

Hematology

Houston, TX20+ years
Hematology & Oncology
Prithviraj Bose

Prithviraj Bose, MD

Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Hematology

Houston, TX20+ years
Hematology & Oncology
David Kuter

David Kuter, MD DPHIL

Director of Clinical Hematology at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School

Oncology

Boston, MA30+ years
Hematology & OncologyMedical Oncology
Amir Fathi

Amir Fathi, M.D.

Professor of Medicine, Harvard Medical School; Program Director, Center for Leukemia, Massachusetts General Hospital

Hematology

Boston, MA20+ years
Hematology & Oncology
Talha Badar

Talha Badar, M.D

Senior Associate Consultant - Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL

Hematology

Jacksonville, FL20+ years
Hematology & Oncology
Joseph Jurcic

Joseph Jurcic, MD

Professor of Medicine; Director, Hematologic Malignancies Section, Division of Hematology/Oncology

Hematology

New York, NY30+ years
Hematology & OncologyMedical Oncology
Jonathan Kolitz

Jonathan Kolitz, MD

Head, Leukemia Service

Hematology

New Hyde Park, NY30+ years
Hematology & Oncology
Ruben Mesa

Ruben Mesa, MD

Enterprise Senior Vice President of Atrium Health; President, Atrium Health Levine Cancer; Executive Director, Atrium Health Wake Forest Baptist Comprehensive Cancer Center; Vice Dean for Cancer Programs; Charles L. Spurr MD Professor of Internal Medicine, Wake Forest University School of Medicine

Hematology

Charlotte, NC30+ years
Hematology & OncologyMedical Oncology
Mark Litzow

Mark Litzow, M.D.

Head, Acute Leukemia Group

Hematology

Rochester, MN30+ years
Myeloid Neoplasms
Ian Flinn

Ian Flinn, M.D.

Hematology

Tullahoma, TN30+ years
Hematology & Oncology
Raajit Rampal

Raajit Rampal, MD

Medical Director, Leukemia Clinical Research; Attending, Hematologic Oncology Service

Oncology

New York, NY15+ years
Hematology & OncologyMedical Oncology
Marlise Luskin

Marlise Luskin, M.D.

Assistant Professor of Medicine, Harvard Medical School; Senior Physician, Dana-Farber Cancer Institute; Educational Director, Adult Leukemia Program, Dana-Farber Cancer Institute; Associate Program Director, Dana-Farber/Mass General Brigham Hematology/Oncology Fellowship Program

Oncology

Boston, MA15+ years
Hematology & OncologyMedical Oncology
Gabriela Hobbs

Gabriela Hobbs, MD

Hematology

Boston, MA15+ years
Hematology & Oncology
John Mascarenhas

John Mascarenhas, MD

Director, Center of Excellence for Blood Cancers and Myeloid Disorders; Director, Adult Leukemia Program

Hematology

New York, NY20+ years
Hematology & Oncology
Robert Lindsley

Robert Lindsley, MD, PHD

Associate Professor of Medicine, Harvard Medical School; Director, Edward P. Evans Center for Myelodysplastic Syndrome; Director of Clinical Genomics in Hematologic Malignancies

Oncology

Boston, MA15+ years
Medical OncologyHematology & Oncology

Myeloproliferative Neoplasms specialists by state

Find myeloproliferative neoplasms specialists in your state.

Frequently Asked Questions

How is this national list of myeloproliferative neoplasms specialists built?
This page includes physicians in Convene Health's public directory whose profile lists Myeloproliferative Neoplasms as a clinical focus area, ranked by composite score (research output, peer recognition, frequency of care, and outcomes signals). Each profile is sourced from the NPI registry, peer-reviewed publication data, board certification records, and the physician's own bio where available.
What should I look for when choosing a myeloproliferative neoplasms specialist?
Start with clinical fit — the right specialist for myeloproliferative neoplasms depends on the specific subtype and severity of your condition. Compare credentials, hospital affiliations, years of experience, peer-reviewed publications, and how the profile describes their approach. Many top specialists are concentrated at academic medical centers; if you have flexibility on location, the top of this list is a strong starting set.
Are these myeloproliferative neoplasms specialists accepting new patients?
Profile detail on availability and accepted insurance varies. Open a specific provider profile to see what they've published about new-patient access, insurance accepted, and typical wait times. Coverage details can change — confirm directly with the practice before your visit.
What is Myeloproliferative Neoplasms?
Myeloproliferative Neoplasms is a clinical focus area covered by the specialists listed here. Each provider profile describes their training, sub-specialties, and the conditions they regularly treat — open a profile for the most authoritative description of how that specific physician approaches myeloproliferative neoplasms care.